News und Analysen
5 must-have next-gen technologies that institutions are buying
Investing in next-gen technologies can lead to early retirement, but knowing which stock will be the next Alphabet (NASDAQ: GOOG), Amazon (NASDAQ: AMZN), or NVIDIA (NASDAQ: NVDA) is hard. One way
Boeing's future sealed as China resumes order flow
Boeing (NYSE: BA) has rallied as much as 22.7% during the past week. This is only the beginning of a significant rally underway, which may help erase the decline in the stock that saw its start as
High-yield, low-beta value plays for buy-and-hold investors
With risk omnipresent in the market and more reason than 1 to fear a recession, value, yield, and beta are more critical for successful investing than ever. If nothing else, volatility should be
Foundational weakness sets Home Depot shares up for another fall
If a rising tide lifts all ships, then a falling 1 can sink them, and a falling tide is what Home Depot (NYSE: HD) and other retailers are facing. The Q3 results were better than expected, but
Capitalizing on value: 3 undervalued stocks ready for resurgence
When it comes down to it, all investing and trading is about nothing more than buying low and selling high. Ideally, you want to find stocks with as much upside as possible and just ride the wave
Bargain alert: 3 large caps with RSIs that scream oversold
Everyone likes to feel like they're getting a bargain when buying something. It's no different when it comes to buying stocks. One of the most widely used technical tools for assessing a stock's
4 high yields near 52-week lows worth looking at
Marketbeat's stock screening tools are a wealth of investment ideas, including the 52-week low list. Stocks trading at 52-week lows often provide oversold value ready to spring back, given the
Can new GPT store spur generative AI monetization?
It’s no big deal to visit the Apple Inc. (NASDAQ: AAPL) app store, Alphabet Inc.’s (NASDAQ: GOOGL) Google Play or Microsoft Corp.’s (NASDAQ: MSFT) store.
ChatGPT operator OpenAI, of which
Microsoft hits record highs as market impact strengthens
Microsoft (NASDAQ: MSFT), the blue-chip tech juggernaut, recently hit an all-time high when the stock hit $370.10 on Friday. With a market capitalization soaring to an impressive $2.75 trillion
3 S&P stocks with growth to weather a downturn
If you’re looking for companies with steady profitability, cash flow and dividends, then Broadcom Inc. (NASDAQ: AVGO), McCormick & Co. Inc. (NYSE: MKC) and Merck & Co. (NYSE: MRK) are worthy
Does Logitech earnings signal the end of tech normalization?
Computer peripherals and accessories manufacturer Logitech International SA (NASDAQ: LOGI) stock has had a tumultuous ride in 2023. Shareholders were surprised when its decade-long CEO, Bracken
Will Eli Lilly's Zepbound be the next big weight-loss drug?
Eli Lilly & Co. (NYSE: LLY) reversed lower on November 9. This came after LLY stock advanced 3.20% after the company got regulators' OK for its weight-loss drug Zepbound.
In clinical trials, the
Interest rates propel insurers' earnings to new highs
It's not as exciting or cutting-edge as technology stocks, but the iShares U.S. Insurance ETF (NYSEARCA: IAK) has been edging higher in the past month.
Ignore this so-called "boring" industry at
Institutional activity provides a bottom for gaming stocks
Roblox (NASDAQ: RBLX) and Take-Two Interactive (NASDAQ: TTWO) produced solid Q3 reports, which is really no surprise. The gaming industry has a loyal following with the release of new titles and
3 reasons Qualcomm might be the easiest buy this month
Up to last week, shares of chipmaker Qualcomm Inc (NASDAQ: QCOM) had been trading largely sideways since this time last year, with several recent attempts from the bears to send them down to fresh
Wall Street sees these 2023 losers as 2024 opportunities
The 2023 version of the U.S. stock market must have recently picked up Johnson & Johnson product Listerine — because it has good…wait for it…‘breadth.’
In investment terminology, market breadth
Profits soar as Airbnb, Intel, Live Nation trounce forecasts
On the surface, Airbnb Inc. (NASDAQ: ABNB), Intel Corp. (NASDAQ: INTC) and Live Nation Entertainment Inc. (NYSE: LYV) don’t seem to have much in common. However, all three recently trounced profit
High financing costs weigh on industrials' growth prospects
It’s one thing to understand what the S&P 500 is doing, by tracking the SPDR S&P 500 ETF Trust (NYSEARCA: SPY). But drilling down a little more gives you a better indication of market breadth, or
Why you can make Vertex Pharmaceuticals a buy on any pullback
Shares of Vertex Pharmaceuticals, Inc. (NASDAQ: VRTX) are down nearly 2% after the company delivered its third-quarter earnings report. The news wasn't particularly bad, although there was a
Occidental Petroleum: Another bounce from the buy zone
It’s yet to be seen whether Warren Buffett and Berkshire Hathaway (NYSE: BRK.A) are involved in the latest bounce in Occidental Petroleum (NYSE: OXY) shares, but it doesn’t matter. The Q3 results
Celsius is growing with no end in sight!
There's a significant opportunity brewing behind the scenes in today's scattered stock market, where the consumer is the only pillar standing strong supporting the latest GDP growth figures
Banking and trucking: Is the economy rolling toward troubles?
The SPDR S&P Regional Banking ETF (NYSEARCA: KRE) closed 1.08% lower on November 6, after a privately held regional bank was closed by the Iowa Division of Banking.
It’s a story of two
You won't believe what Buffett's latest investments reveal
It is no secret that Warren Buffett's baby-turned-giant, Berkshire Hathaway (NYSE: BRK.A), has been piling up a record level of cash on hand. This can only mean two things are top of mind for the
3 payroll companies get clocked, but 1 looks cheap
Payroll companies alleviate the complexities of processing payrolls. They withhold taxes, apply payments to various government agencies, track employee hours, track benefits, comply with
Pfizer and Sanofi shares fall, which one to scoop up?
Pharmaceutical stocks aren't having quite the banner year they've had in the past. Notably, two large pharmaceutical companies recently plunged to 52-week lows on their earnings results. Many